STAT October 17, 2024
Mario Aguilar

Blue Note’s failure holds lessons for other digital therapeutics startups

The bad news didn’t come all at once for Blue Note Therapeutics, but a final denial from the Food and Drug Administration in January proved to be the final blow.

In late 2023, after a rejection from the agency earlier in the year, Blue Note had made a last...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Technology
There’s a new game in town for D2C health business models
Telehealth Companies Boost Ad Spending While Taking on More Complex Medicine
Health systems' top 4 digital transformation trends in '25
Redefining Storage to Enable Digital Twins
Connected health tools help seniors, but a digital divide persists

Share This Article